Close

Saneca Pharma strengthens team with new sales director

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has strengthened its team with the appointment of a new CDMO sales director as it continues to implement its global growth strategy.

With nearly 30 years’ experience in the industry, having held positions in a number of worldwide CDMO and contract research companies, Markus Saal joins the senior team at Saneca to head up its finished dosage form (FDF) sales and business development activity.

He will work alongside Jan Bakta who will continue to lead its active pharmaceutical ingredient (API) business.

Anthony Sheehan, CEO at Saneca Pharma said: “We are already the largest pharmaceutical manufacturer and employer in Slovakia and have a strategic growth strategy in place to expand our customer base and service offering. We’re delighted to welcome kus to the team to drive our plans forward.

Having worked across Europe, the US, the Middle East and Asia, Markus brings a wealth of industry knowledge and experience to the CDMO as it prepares for its next phase of growth.

Markus said, “Saneca’s technical agility and decades of experience are key differentiators in its service offering, as is its ability to cater for the entire drug development process, including API and FDF manufacturing processes. It’s great to be part of a team so committed to achieving its goals.”

Based in western Slovakia, in close proximity to Vienna, Saneca Pharma offers its customers strong capabilities in solids, semi-solids and liquids, as well as specialist expertise in the development and manufacture of opiate active pharmaceutical ingredients (APIs) and finished dosage forms from farm to pharmacy.

About Saneca Pharma
Based in Hlohovec, Slovakia, with close proximity to Vienna, Budapest and Prague, Saneca Pharma develops and manufactures a variety of finished dosage forms, with strong capabilities in solids and semi-solids and specialist expertise in the development of opiate APIs and final dosage forms from farm to pharmacy.

Saneca Pharma has a proud’ big pharma’ heritage and combines a strong track record of consistent supply and uncompromising quality, with a unique breadth of services, technical agility and dedicated experts to deliver responsive solutions.

For further information please visit www.saneca.com

Latest stories